Page last updated: 2024-10-30

leflunomide and Latent Tuberculosis

leflunomide has been researched along with Latent Tuberculosis in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Latent Tuberculosis: The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.

Research Excerpts

ExcerptRelevanceReference
" In the multivariable model, the steroids dosage was a significant and independent predictor of negative ppd (p = 0."1.36Prevalence of positive ppd in a cohort of rheumatoid arthritis patients. ( Debonis, J; Mysler, E; Schijedman, A; Tamborenea, MN; Tate, G, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tamborenea, MN1
Tate, G1
Mysler, E1
Debonis, J1
Schijedman, A1
Kwakernaak, AJ1
Houtman, PM1
Weel, JF1
Spoorenberg, JP1
Jansen, TL1

Other Studies

2 other studies available for leflunomide and Latent Tuberculosis

ArticleYear
Prevalence of positive ppd in a cohort of rheumatoid arthritis patients.
    Rheumatology international, 2010, Volume: 30, Issue:5

    Topics: Adult; Aged; Antirheumatic Agents; Argentina; Arthritis, Rheumatoid; Biological Products; Cross-Sect

2010
A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.
    Clinical rheumatology, 2011, Volume: 30, Issue:4

    Topics: Arthritis, Rheumatoid; Azathioprine; Biological Assay; CD4-Positive T-Lymphocytes; Female; Glucocort

2011